CS
NXGN

Credit Suisse’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Credit Suisse’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-174,424
Closed -$4.14M – 3190
2023
Q3 		$4.14M Buy
174,424
+104,425
+149% +$1.97M ﹤0.01% 1374
2023
Q2 		$1.14M Buy
69,999
+768
+1% +$12.7K ﹤0.01% 2300
2023
Q1 		$1.21M Buy
69,231
+4,449
+7% +$80K ﹤0.01% 2215
2022
Q4 		$1.22M Buy
64,782
+13,653
+27% +$263K ﹤0.01% 2208
2022
Q3 		$906K Buy
51,129
+4,842
+10% +$84K ﹤0.01% 2401
2022
Q2 		$807K Sell
46,287
-5,193
-10% -$99K ﹤0.01% 2530
2022
Q1 		$1.08M Buy
51,480
+3,614
+8% +$69.2K ﹤0.01% 2496
2021
Q4 		$852K Buy
47,866
+2,776
+6% +$44.6K ﹤0.01% 3440
2021
Q3 		$636K Sell
45,090
-2,956
-6% -$46K ﹤0.01% 3650
2021
Q2 		$797K Sell
48,046
-18,841
-28% -$338K ﹤0.01% 3547
2021
Q1 		$1.21M Buy
66,887
+43,328
+184% +$855K ﹤0.01% 3200
2020
Q4 		$430K Buy
+23,559
New +$374K ﹤0.01% 3868
2020
Q1 		– Sell
-49,268
Closed -$792K – 4313
2019
Q4 		$792K Sell
49,268
-5,927
-11% -$97.9K ﹤0.01% 3286
2019
Q3 		$865K Buy
55,195
+836
+2% +$13.9K ﹤0.01% 3108
2019
Q2 		$1.08M Buy
54,359
+2,943
+6% +$55K ﹤0.01% 2886
2019
Q1 		$865K Sell
51,416
-3,078
-6% -$53.4K ﹤0.01% 2999
2018
Q4 		$825K Buy
54,494
+7,373
+16% +$126K ﹤0.01% 2928
2018
Q3 		$946K Sell
47,121
-15,691
-25% -$333K ﹤0.01% 2914
2018
Q2 		$1.23M Sell
62,812
-22,445
-26% -$355K ﹤0.01% 2856
2018
Q1 		$1.16M Sell
85,257
-16,467
-16% -$217K ﹤0.01% 2854
2017
Q4 		$1.38M Buy
101,724
+14,567
+17% +$209K ﹤0.01% 2755
2017
Q3 		$1.37M Buy
87,157
+32,489
+59% +$524K ﹤0.01% 2874
2017
Q2 		$940K Sell
54,668
-23,254
-30% -$353K ﹤0.01% 2741
2017
Q1 		$1.19M Sell
77,922
-9,657
-11% -$142K ﹤0.01% 2735
2016
Q4 		$1.15M Buy
87,579
+18,842
+27% +$241K ﹤0.01% 2912
2016
Q3 		$778K Sell
68,737
-42,250
-38% -$507K ﹤0.01% 3153
2016
Q2 		$1.32M Buy
110,987
+47,385
+75% +$637K ﹤0.01% 2679
2016
Q1 		$969K Buy
63,602
+8,336
+15% +$126K ﹤0.01% 2750
2015
Q4 		$890K Sell
55,266
-16,698
-23% -$244K ﹤0.01% 2912
2015
Q3 		$899K Buy
71,964
+2,432
+3% +$33.4K ﹤0.01% 2907
2015
Q2 		$1.15M Buy
69,532
+7,959
+13% +$128K ﹤0.01% 3039
2015
Q1 		$985K Sell
61,573
-398
-0.6% -$6.58K ﹤0.01% 2986
2014
Q4 		$966K Sell
61,971
-4,836
-7% -$70.7K ﹤0.01% 3158
2014
Q3 		$919K Sell
66,807
-68,339
-51% -$1.04M ﹤0.01% 3131
2014
Q2 		$2.17M Buy
135,146
+24,049
+22% +$380K ﹤0.01% 2644
2014
Q1 		$1.88M Sell
111,097
-82,435
-43% -$1.49M ﹤0.01% 2556
2013
Q4 		$4.07M Buy
193,532
+73,666
+61% +$1.66M ﹤0.01% 2008
2013
Q3 		$2.6M Buy
119,866
+54,491
+83% +$1.16M ﹤0.01% 2173
2013
Q2 		$1.22M Buy
+65,375
New +$1.19M ﹤0.01% 2639

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Suisse's NXGN Position: Q4 2023 in Review

Credit Suisse sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 174,424 shares — an estimated $4.14M sold.

Credit Suisse first reported a position in NXGN in Q2 2013 and held it in 39 quarters. The position peaked at $4.14M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Credit Suisse reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 174,424 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $4.14M.
  • Credit Suisse first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 39 quarters.
  • Credit Suisse's NextGen Healthcare, Inc. Common Stock position peaked at $4.14M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.